MCL1 and B-cell chronic lymphocytic leukemia: Although MCL1 appears to confer CLL resistance to venetoclax [27-29], MCL1 is also essential for the maintenance of cardiac cells [44,45] and long-lived plasma cells within BM [46,47], making its targeting problematic.